Viral and host correlates of serum resistin in simian AIDS

AIDS Research and Human Retroviruses

Volumn 24, Issue 1, 2008, Pages 34-42

  Wachtman, L M ^a   Gualtieri, L ^b   Wanke, C ^b   Shannon, R ^c   Mansfield, K G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; DISEASE SEVERITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; INSULIN RESISTANCE; LYMPHOCYTE SUBPOPULATION; MONKEY DISEASE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS REPLICATION;

ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HUMANS; INSULIN RESISTANCE; MACACA MULATTA; RESISTIN; SEVERITY OF ILLNESS INDEX; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

EID: 38149111312     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0154     Document Type: Article

References (40)

1. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton DL, and Hebert CC: FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000;19:4046-4055.
2. Kim KH, Lee K, Moon YS, and Sul HS: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276:11252-11256.
3. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, and Lazar MA: The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
4. Lee JH, Bullen JW Jr, Stoyneva VL, and Mantzoros CS: Circulating resistin in lean, obese, and insulin-resistant mouse models: Lack of association with insulinemia and glycemia. Am J Physiol Endocrinol Metab 2005;288:E625-632.
5. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q, and Considine RV: Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003;88:5452-5455.
6. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, and Richart C: Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: Relationships in obesity. Obes Res 2004;12:962-971.
7. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, and Mantzoros CS: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003;88:4848-4856.
8. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, and Murphy LJ: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: Correlations with insulin resistance. Eur J Endocrinol 2003;149:331-335.
9. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, and O'Rahilly S: Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001;50:2199-2202.
10. Janke J, Engeli S, Gorzelniak K, Luft FC, and Sharma AM: Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 2002;10:1-5.
11. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, and Kumar S: Resistin, central obesity, and type 2 diabetes. Lancet 2002;359:46-47.
12. Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, Cho YM, Park YJ, Kim SY, Lee HK, and Park KS: Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004;89:150-156.
13. Pfutzner A, Langenfeld M, Kunt T, Lobig M, and Forst T: Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 2003;49:571-576.
14. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, and Lazar MA: An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004;1:e45.
15. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, and Patsch JR: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003;309:286-290.
16. Stejskal D, Adamovska S, Bartek J, Jurakova R, and Proskova J: Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003;147:63-69.
17. Bokarewa M, Nagaev I, Dahlberg L, Smith U, and Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005;174:5789-5795.
18. Silswal N, Singh A, Aruna B, Mukhopadhyay S, Ghosh S, and Ehtesham NZ: Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway. Biochem Biophys Res Commun 2005;334:1092-1101.
19. Deeks SG, Kitchen CMR, Liu L, Guo H, Gascon R, Narvaez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, and Hecht FM: Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004;104:942-947.
20. Lifson JD, Nowack MA, Goldstein S, Rossio JL, Kinter A, Vasquez G, Wiltrout TA, Brown C, Schneider D, Wahl L, Lloyd AL, Wiliams J, Elkins WR, Fauci AS, and Hirsch VM: The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol 1997;71:9508-9514.
21. Hazenberg MD, Hamann D, Schuitemaker H, and Miedema F: T cell depletion in HIV-1 infection: How CD4+ T cells go out of stock. Nat Immunol 2000;1:285-289.
22. Barb D, Wadhwa SG, Kratzsch J, Gavrila A, Chan JL, Williams CJ, Karchmer AW, and Mantzoros CS: Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with highly active antiretroviral therapy-induced metabolic syndrome. J Clin Endocrinol Metab 2005;90:5324-5328.
23. Kamin D, Hadigan C, Lehrke M, Mazza S, Lazar MA, and Grinspoon S: Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone. J Clin Endocrinol Metab 2005;90:3423-3426.
24. Freeman LM, Mansfield KG, Goldin B, Woods M, Gualtieri L, Li W, Bussell S, Lackner A, and Gorbach SL: Body-composition changes in the simian immunodeficiency virus-infected juvenile rhesus macaque. J Infect Dis 2004;189:2010-2015.
25. Goldin BR, Li W, Mansfield K, Woods M, Wanke C, Freeman L, Shevitz A, Gualtieri L, Bussell S, and Gorbach SL: The effect of micronutrient supplementation on disease progression and death in simian immunodeficiency virus-infected juvenile male rhesus macaques. J Infect Dis 2005;192:311-318.
26. Fahey JL, Taylor JM, Manna B, Nishanian P, Aziz N, Giorgi JV, and Detels R: Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 1998;12:1581-1590.
27. + T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions. J Virol 2005;79:6299-6311.
28. Christiansen T, Richelsen B, and Bruun JM: Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 2005;29:146-150.
29. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, and Leonard EJ: Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989;169:1449-1459.
30. Bruun JM, Lihn AS, Pedersen SB, and Richelsen B: Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): Implication of macrophages resident in the AT. J Clin Endocrinol Metab 2005;90:2282-2289.
31. Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, and Dandona P: Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab 2004;89:2728-2735.
32. Fu Y, Luo N, and Garvey WT: Proinflammatroy cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes. Nutr Metab (Lond) 2006;3:28.
33. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, and Bouloumie A: Macrophages in human visceral adipose tissue: Increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006;49:744-747.
34. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, and Kasuga M: MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116:1494-1505.
35. Dinarello CA: IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
36. Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, and Prokopowicz D: Plasma interleukin-18 is associated with viral load and disease progression in HIV-1-infected patients. Microbes Infect 2004;6:1273-1277.
37. Esposito K, Pontillo A, Ciotola M, Di Palo C, Grella E, Nicoletti G, and Giugliano D: Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 2002;87:3864-3866.
38. Lindegaard B, Hansen AB, Gerstoft J, and Pedersen BK: High plasma level of interleukin-18 in HIV-infected subjects with lipodystrophy. J Acquir Immune Defic Syndr 2004;36:588-593.
39. Otake K, Omoto S, Yamamoto T, Okuyama H, Okada H, Okada N, Kawai M, Saksena NK, and Fujii YR: HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors. AIDS 2004;18:189-198.
40. Tejero ME, Freeland-Graves JH, Proffitt JM, Peebles KW, Cai G, Cole SA, and Comuzzie AG: Adiponectin but not resistin is associated with insulin resistance-related phenotypes in baboons. Obes Res 2004;12:871-877.